From obesity to diabetes and cancer: epidemiological links and role of therapies (Q26767027)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3 references

27 October 2020

4 February 2021

8 February 2021

From obesity to diabetes and cancer: epidemiological links and role of therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

27 October 2020

2 references

3 April 2019

8 February 2021

2 references

27 October 2020

4 February 2021

anti-diabetic medication

1 reference

27 October 2020

José Manuel García-Martínez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Antonio De la Vieja

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Custodia García-Jiménez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

María Gutiérrez-Salmerón

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ana Chocarro-Calvo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Angel Castaño

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

23 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

8 March 2020

29 March 2016

3 references

27 October 2020

4 February 2021

8 February 2021

11 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

3 April 2019

20 August 2019

6 September 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

27 October 2020

4 February 2021

8 February 2021

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

716-722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

8 March 2020

copyright license

10 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

3 April 2019

20 August 2019

6 September 2019

27 October 2020

4 February 2021

on focus list of Wikimedia project

8 February 2021

ScienceSource

0 references

cites work

Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Is cancer a metabolic disease?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

mTOR inhibitors and diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Cancer cachexia: understanding the molecular basis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Antihyperglycaemic therapies and cancer risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Latest insights into the risk of cancer in diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Obesity: an epidemiological perspective from Asia and its relationship to gastrointestinal and liver cancers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Diabetes and risk of cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Glargine safety, diabetes and cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Diabetes mellitus and cancer risk: review of the epidemiological evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Prostate carcinogenesis with diabetes and androgen-deprivation-therapy-related diabetes: an update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Insulin analogues and cancer risk: cause for concern or cause célèbre?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Cancer incidence and mortality after gastric bypass surgery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Altered glucose metabolism during chemoradiation for head and neck cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: results from a single-centre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Glycemic index, glycemic load and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Diabetes mellitus following cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Fasting blood glucose and lipid profile alterations following twelve-month androgen deprivation therapy in men with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2016.37

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4984860

Author reply: To PMID 23208166

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26908326

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Corticosteroid-induced diabetes in palliative care

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26908326

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/26908326

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2016.37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

PubMed publication ID

26908326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908326%20AND%20SRC:MED&resulttype=core&format=json